Network pharmacology of xylazine to understand its health consequences and develop mechanistic-based remediations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Network pharmacology of xylazine to understand its health consequences and develop mechanistic-based remediations ; volume:4 ; number:2 ; year:2024 ; pages:24-33
German journal of veterinary research ; 4, Heft 2 (2024), 24-33
- Klassifikation
-
Tiere
- Urheber
-
Kumar, Arun HS
- Beteiligte Personen und Organisationen
-
Stemcology, School of Veterinary Medicine, University College Dublin, Belfield, Dublin-04, Ireland
- DOI
-
10.51585/gjvr.2024.2.0082
- URN
-
urn:nbn:de:101:1-2410232142194.955651197353
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kumar, Arun HS
- Stemcology, School of Veterinary Medicine, University College Dublin, Belfield, Dublin-04, Ireland
Ähnliche Objekte (12)
Lymphatic Interrupted: Do We Really Understand the Risks and Consequences?
International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases
Embracing Technology to Develop a Clinical Pharmacology and Medication Safety Elective in Undergraduate Medical Education
Pharmacology
Pharmacology
Pharmacology
Respiratory pharmacology
Clinical pharmacology
BMC pharmacology
Generator-specific ROS production within mitochondria - from mechanistic understanding to functional consequences
MonoDevelop
From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling
Lymphatic Interrupted: Do We Really Understand the Risks and Consequences?
International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases
Embracing Technology to Develop a Clinical Pharmacology and Medication Safety Elective in Undergraduate Medical Education
Pharmacology
Pharmacology
Pharmacology
Respiratory pharmacology
Clinical pharmacology
BMC pharmacology
Generator-specific ROS production within mitochondria - from mechanistic understanding to functional consequences
MonoDevelop
From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling
Lymphatic Interrupted: Do We Really Understand the Risks and Consequences?
International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases
Embracing Technology to Develop a Clinical Pharmacology and Medication Safety Elective in Undergraduate Medical Education
Pharmacology
Pharmacology
Pharmacology
Respiratory pharmacology
Clinical pharmacology
BMC pharmacology
Generator-specific ROS production within mitochondria - from mechanistic understanding to functional consequences
MonoDevelop